Latest Diabetes: Type II news
Finerenone + Empagliflozin Offers Greater Benefit in CKD, T2DM
posted June 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
Concurrent Hypertension + Type 2 Diabetes Predict High Mortality Risk
posted June 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists
posted April 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Sodium-Glucose Cotransporter 2 Inhibitors Increase Risk for Falls in Patients With Diabetes
posted April 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis Related Articles
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes Monthly Specialist Briefings
Stay Connected
